FDA rejects approval of epinephrine nasal spray – CBS News
The Food and Drug Administration on Tuesday declined to approve Neffy, an epinephrine nasal spray that offers a needle-free alternative for treating severe allergic reactions. The FDA said Neffy needs more research.
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.